Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2723294 | The American Journal of Medicine | 2012 | 10 Pages |
Abstract
The angiotensin II receptor blocker and calcium channel blocker combination lowered blood pressure more than the high-dose angiotensin II receptor blocker and reduced the incidence of primary end points more than the high-dose angiotensin II receptor blocker in patients with cardiovascular disease. The addition of a second antihypertensive agent is more effective at lowering blood pressure than simply doubling the dose of an existing agent.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Hisao MD, Shokei MD, PhD, Kunihiko MD, Tomio MD, Hideaki MD, Kikuo MD, OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Group OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Group,